SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Zim Laboratories informs about acquisition of equity shares of ZIMTAS

09 Apr 2026 Evaluate

With reference to the above and pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (SEBI LODR), Zim Laboratories has informed that out of the approved investment amount of up to Rs 2.00 crore, the company has invested Rs 89.45 lakh which is 1,35,000 Australian Dollars in the equity shares of ZIMTAS. Post investment, the company holds 99.96% of the total share capital of ZIMTAS.

The above information is a part of company’s filings submitted to BSE.

Zim Laboratories Share Price

123.00 -0.10 (-0.08%)
03-Jul-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1904.65
Dr. Reddys Labs. 1374.55
Cipla 1458.45
Zydus Lifesciences 1141.00
Lupin 2476.10
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: